1,655
Views
17
CrossRef citations to date
0
Altmetric
Reports

p53 directly regulates the glycosidase FUCA1 to promote chemotherapy-induced cell death

, , , , &
Pages 2299-2308 | Received 22 Apr 2016, Accepted 14 May 2016, Published online: 03 Aug 2016

References

  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
  • Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408:307-10; PMID:11099028; http://dx.doi.org/10.1038/35042675
  • Beroud C, Soussi T. The UMD-p53 database: new mutations and analysis tools. Human mutation 2003; 21:176-81; PMID:12619103; http://dx.doi.org/10.1002/humu.10187
  • Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Jr., Butel JS, Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356:215-21; PMID:1552940; http://dx.doi.org/10.1038/356215a0
  • Attardi LD. The role of p53-mediated apoptosis as a crucial anti-tumor response to genomic instability: lessons from mouse models. Mutat Res 2005; 569:145-57; PMID:15603759; http://dx.doi.org/10.1016/j.mrfmmm.2004.04.019
  • Bieging KT, Attardi LD. Deconstructing p53 transcriptional networks in tumor suppression. Trends Cell Biol 2012; 22:97-106; PMID:22154076; http://dx.doi.org/10.1016/j.tcb.2011.10.006
  • Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 2001; 7:683-94; PMID:11463392; http://dx.doi.org/10.1016/S1097-2765(01)00214-3
  • Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 2001; 7:673-82; PMID:11463391; http://dx.doi.org/10.1016/S1097-2765(01)00213-1
  • Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000; 288:1053-8; PMID:10807576; http://dx.doi.org/10.1126/science.288.5468.1053
  • Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, Roth JA, Deisseroth AB, Zhang WW, Kruzel E, et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 1995; 15:3032-40; PMID:7539102; http://dx.doi.org/10.1128/MCB.15.6.3032
  • Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, Green DR. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004; 303:1010-4; PMID:14963330; http://dx.doi.org/10.1126/science.1092734
  • Leu JI, Dumont P, Hafey M, Murphy ME, George DL. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 2004; 6:443-50; PMID:15077116; http://dx.doi.org/10.1038/ncb1123
  • Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, Moll UM. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003; 11:577-90; PMID:12667443; http://dx.doi.org/10.1016/S1097-2765(03)00050-9
  • Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74:957-67; PMID:8402885; http://dx.doi.org/10.1016/0092-8674(93)90719-7
  • Crighton D, Ryan KM. Splicing DNA-damage responses to tumour cell death. Biochim Biophys Acta 2004; 1705:3-15; PMID:15585169
  • Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature 1997; 387:299-303; PMID:9153396; http://dx.doi.org/10.1038/387299a0
  • Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997; 387:296-9; PMID:9153395; http://dx.doi.org/10.1038/387296a0
  • Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer 2015; 15:540-55; PMID:26289314; http://dx.doi.org/10.1038/nrc3982
  • Varki A, Kannagi R, Toole BP. Glycosylation Changes in Cancer. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, eds. Essentials of Glycobiology. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press. The Consortium of Glycobiology Editors, La Jolla, California, 2009.
  • Ryan KM, O'Prey J, Vousden KH. Loss of nuclear factor-kappaB is tumor promoting but does not substitute for loss of p53. Cancer Res 2004; 64:4415-8.
  • Dickins RA, Hemann MT, Zilfou JT, Simpson DR, Ibarra I, Hannon GJ, Lowe SW. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat Genet 2005; 37:1289-95; PMID:16200064
  • Long JS, Crighton D, O'Prey J, Mackay G, Zheng L, Palmer TM, Gottlieb E, Ryan KM. Extracellular adenosine sensing-a metabolic cell death priming mechanism downstream of p53. Molecular Cell 2013; 50:394-406; PMID:23603120; http://dx.doi.org/10.1016/j.molcel.2013.03.016
  • Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D, Dyson N, Harlow E. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev 1993; 7:1111-25; PMID:8319904; http://dx.doi.org/10.1101/gad.7.7a.1111
  • Baudot AD, Haller M, Mrschtik M, Tait SW, Ryan KM. Using enhanced-mitophagy to measure autophagic flux. Methods 2015; 75:105-11; PMID:25498004; http://dx.doi.org/10.1016/j.ymeth.2014.11.014
  • Ryan KM, Ernst MK, Rice NR, Vousden KH. Role of NF-kappaB in p53-mediated programmed cell death. Nature 2000; 404:892-7; PMID:10786798; http://dx.doi.org/10.1038/35009130
  • Pellicciari C, Manfredi AA, Bottone MG, Schaack V, Barni S. A single-step staining procedure for the detection and sorting of unfixed apoptotic thymocytes. Eur J Histochem 1993; 37:381-90; PMID:7510545
  • Tanikawa C, Matsuda K, Fukuda S, Nakamura Y, Arakawa H. p53RDL1 regulates p53-dependent apoptosis. Nat Cell Biol 2003; 5:216-23; PMID:12598906; http://dx.doi.org/10.1038/ncb943
  • Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR, Gasco M, Garrone O, Crook T, Ryan KM. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006; 126:121-34; PMID:16839881; http://dx.doi.org/10.1016/j.cell.2006.05.034
  • el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-25; PMID:8242752; http://dx.doi.org/10.1016/0092-8674(93)90500-P
  • Hoh J, Jin S, Parrado T, Edington J, Levine AJ, Ott J. The p53MH algorithm and its application in detecting p53-responsive genes. Proc Natl Acad Sci U S A 2002; 99:8467-72; PMID:12077306; http://dx.doi.org/10.1073/pnas.132268899
  • Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282:1497-501; PMID:9822382; http://dx.doi.org/10.1126/science.282.5393.1497
  • Johnson SW, Alhadeff JA. Mammalian alpha-L-fucosidases. Comp Biochem Physiol B 1991; 99:479-88; PMID:1769200; http://dx.doi.org/10.1016/0305-0491(91)90327-A
  • Tsay GC, Dawson G, Sung SS. Structure of the accumulating oligosaccharide in fucosidosis. J Biol Chem 1976; 251:5852-9; PMID:972144
  • Winchester B. Lysosomal metabolism of glycoproteins. Glycobiology 2005; 15:1r-15r; PMID:15647514; http://dx.doi.org/10.1093/glycob/cwi041
  • Yamashita K, Tachibana Y, Takada S, Matsuda I, Arashima S, Kobata A. Urinary glycopeptides of fucosidosis. J Biol Chem 1979; 254:4820-7; PMID:438217
  • Rapoport E, Pendu JL. Glycosylation alterations of cells in late phase apoptosis from colon carcinomas. Glycobiology 1999; 9:1337-45; PMID:10561459; http://dx.doi.org/10.1093/glycob/9.12.1337
  • Willems PJ, Gatti R, Darby JK, Romeo G, Durand P, Dumon JE, O'Brien JS. Fucosidosis revisited: a review of 77 patients. Am J Med Genet 1991; 38:111-31; PMID:2012122; http://dx.doi.org/10.1002/ajmg.1320380125
  • Willems PJ, Seo HC, Coucke P, Tonlorenzi R, O'Brien JS. Spectrum of mutations in fucosidosis. Eur J Hum Genet 1999; 7:60-7; PMID:10094192; http://dx.doi.org/10.1038/sj.ejhg.5200272
  • Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994; 371:346-7; PMID:8090205; http://dx.doi.org/10.1038/371346a0
  • Melino G, Bernassola F, Ranalli M, Yee K, Zong WX, Corazzari M, Knight RA, Green DR, Thompson C, Vousden KH. p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. J Biol Chem 2004; 279:8076-83; PMID:14634023; http://dx.doi.org/10.1074/jbc.M307469200
  • Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997; 90:809-19; PMID:9288759; http://dx.doi.org/10.1016/S0092-8674(00)80540-1
  • Jost CA, Marin MC, Kaelin WG, Jr. p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 1997; 389:191-4; PMID:9296498; http://dx.doi.org/10.1038/38298
  • Crighton D, O'Prey J, Bell HS, Ryan KM. p73 regulates DRAM-independent autophagy that does not contribute to programmed cell death. Cell Death Differ 2007; 14:1071-9; PMID:17304243; http://dx.doi.org/10.1038/sj.cdd.4402108
  • Long JS, Schoonen PM, Graczyk D, O'Prey J, Ryan KM. p73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death. Oncogene 2015; 34:5152-62; PMID:25659586; http://dx.doi.org/10.1038/onc.2014.436
  • Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80:293-9; PMID:7834749; http://dx.doi.org/10.1016/0092-8674(95)90513-8
  • Mehta A, Block TM. Fucosylated glycoproteins as markers of liver disease. Dis Markers 2008; 25:259-65; PMID:19126969; http://dx.doi.org/10.1155/2008/264594
  • Warnes TW, Smith A. Tumour markers in diagnosis and management. Bailliere's Clin Gastroenterol 1987; 1:63-89; PMID:2437983